- Home
- RGNX vs LAC Comparison
RGNX vs LAC Comparison
Compare RGNX & LAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGNX
- LAC
- Stock Information
- Founded
- RGNX 2008
- LAC 2023
- Country
- RGNX United States
- LAC Canada
- Employees
- RGNX N/A
- LAC N/A
- Industry
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- LAC Metal Mining
- Sector
- RGNX Health Care
- LAC Basic Materials
- Exchange
- RGNX Nasdaq
- LAC Nasdaq
- Market Cap
- RGNX 661.2M
- LAC 722.6M
- IPO Year
- RGNX 2015
- LAC N/A
- Fundamental
- Price
- RGNX $13.08
- LAC $5.56
- Analyst Decision
- RGNX Strong Buy
- LAC Hold
- Analyst Count
- RGNX 7
- LAC 8
- Target Price
- RGNX $30.00
- LAC $5.44
- AVG Volume (30 Days)
- RGNX 602.9K
- LAC 62.7M
- Earning Date
- RGNX 11-06-2025
- LAC 11-07-2025
- Dividend Yield
- RGNX N/A
- LAC N/A
- EPS Growth
- RGNX N/A
- LAC N/A
- EPS
- RGNX N/A
- LAC N/A
- Revenue
- RGNX $155,782,000.00
- LAC N/A
- Revenue This Year
- RGNX $198.02
- LAC N/A
- Revenue Next Year
- RGNX $2.67
- LAC N/A
- P/E Ratio
- RGNX N/A
- LAC N/A
- Revenue Growth
- RGNX 74.95
- LAC N/A
- 52 Week Low
- RGNX $5.04
- LAC $2.31
- 52 Week High
- RGNX $13.93
- LAC $10.52
- Technical
- Relative Strength Index (RSI)
- RGNX 57.58
- LAC 42.66
- Support Level
- RGNX $12.66
- LAC $6.37
- Resistance Level
- RGNX $13.93
- LAC $6.02
- Average True Range (ATR)
- RGNX 0.69
- LAC 0.73
- MACD
- RGNX -0.05
- LAC -0.39
- Stochastic Oscillator
- RGNX 57.85
- LAC 0.59
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
About LAC Lithium Americas Corp.
Lithium Americas is a pure-play lithium producer. The firm owns 62% of one resource, Thacker Pass, which is located in northwest Nevada, with automaker General Motors owning the remaining 38%. Thacker Pass is under construction and expected to begin production in 2028. Thacker Pass is one of the largest known lithium resources in the world. The project would be the first clay-based asset to enter production, and we estimate it will be in bottom half of the global cost curve. Management plans to develop Thacker Pass into a fully integrated lithium production site, with downstream refining capabilities on site, and will sell into the lithium chemical market.